In a bold move to cement India’s status as a global leader in pharmaceuticals, the ‘India Pharma 2026’ summit is poised to accelerate the sector’s evolution. Scheduled for April 13-14 in New Delhi, this ninth edition underscores a visionary shift from volume-based production to high-value innovation.
The Department of Pharmaceuticals, collaborating with FICCI and the Indian Pharmaceutical Alliance, will host the event under the auspices of the Ministry of Chemicals and Fertilizers. Inauguration by heavyweights JP Nadda and Anupriya Patel signals the government’s unwavering commitment to pharma excellence.
Under the compelling theme ‘Discover in India: Leapfrogging Life-Sciences Innovation,’ participants will explore how India can amplify its R&D prowess, strengthen supply chains, and expand healthcare reach globally. The conference serves as a vital platform for forging partnerships that drive economic momentum and resilient health infrastructures.
Leveraging its role as a supplier of cost-effective medicines, India is now targeting the innovation frontier. India Pharma 2026 will chart the course for becoming a powerhouse in novel therapies, biotech, and life sciences, attracting investments and talent worldwide.
Key speakers like Manoj Joshi, Punya Salila Srivastava, Vinod K. Paul, Renu Swarup, and Shivakumar Kalyanaraman will share insights across six plenary sessions and innovative formats like the Startup Showcase. This two-day powerhouse event promises candid dialogues on policy, technology, and future-ready strategies.
As India eyes 2026 and beyond, this summit stands as a declaration of intent: to not just participate in global pharma, but to lead it with groundbreaking innovation.
